Valuations for Private Equity and Venture Capital Transactions

PE and VC transactions turn on two numbers: the valuation at which primary equity is issued, and the relative value of the preferred instruments the investor receives. Getting either wrong costs the company either dilution it should not have given, or term-sheet protections it cannot defend at exit. Transique prepares independent pre-money and post-money valuations, preferred-versus-common analyses, ESOP valuations and pre-IPO cross-over valuations that stand up to investor-committee scrutiny and auditor review.

Our PE and VC valuations are prepared under the International Valuation Standards, and — for companies preparing for an IPO — in alignment with SEBI ICDR pricing frameworks and Ind AS 113 fair-value measurement principles.

• You are raising a PE / VC round and need an independent valuation to benchmark investor indications.
• You are a PE or VC fund carrying out periodical valuations on portfolio companies (see Portfolio Valuation page for fund-level engagements).
• You are issuing ESOPs and require a defensible fair-market-value determination for grant pricing.
• You are structuring a convertible instrument (CCPS, OCDs, SAFE-equivalents) and need relative-value analysis.
• You are raising a pre-IPO round and need a valuation that will reconcile with post-listing IPO pricing.

• Pre-money and post-money enterprise-value and equity-value analysis.
• Comparable-companies and comparable-transactions multiples analysis.
• DCF-based valuation with sensitivity, scenario analysis where relevant.
• Preferred vs common allocation using Option-Pricing Method (OPM), PWERM or hybrid frameworks.
• ESOP fair-market-value report using Black Scholes or Binomial valuation methods at grant date.
• Written valuation report compliant with International Valuation Standards.

• Scope definition. Purpose, reference date, instruments, and reporting audience clarified in writing.
• Input gathering. Historical financials, projections, cap table, existing investor rights, industry data, comparable universe.
• Methodology selection. DCF, relative, or asset-based — typically triangulated.
• Sensitivity and allocation. Preferred-share features (liquidation preference, participation, conversion, anti-dilution) modelled through OPM.
• Review and sign-off. Internal technical review; senior-partner sign-off; report issued as IBBI-Registered Valuer.

• OPM / PWERM / hybrid allocation frameworks tailored to term-sheet specifics.
• Sensitivity to discount rate, terminal growth, and revenue-trajectory inputs.
• Calibration to recent primary / secondary transactions in the subject company (when available).